 Maria Gore
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Angiopathies | 6 | 2015 | 244 | 1.530 |
Why?
| | Cardiovascular Diseases | 10 | 2020 | 1727 | 1.450 |
Why?
| | Diabetes Mellitus, Type 2 | 14 | 2016 | 2096 | 1.230 |
Why?
| | Myocardial Infarction | 7 | 2015 | 927 | 1.140 |
Why?
| | Troponin T | 3 | 2020 | 49 | 1.140 |
Why?
| | Hypoglycemic Agents | 7 | 2015 | 1013 | 0.890 |
Why?
| | Blood Donors | 2 | 2015 | 89 | 0.870 |
Why?
| | Diabetes Mellitus | 3 | 2015 | 900 | 0.770 |
Why?
| | Veterinary Medicine | 1 | 2019 | 6 | 0.650 |
Why?
| | Prediabetic State | 3 | 2015 | 219 | 0.580 |
Why?
| | Hospice Care | 1 | 2019 | 185 | 0.510 |
Why?
| | Pain | 2 | 2019 | 705 | 0.480 |
Why?
| | Thiazolidinediones | 5 | 2015 | 142 | 0.470 |
Why?
| | Hyperglycemia | 2 | 2015 | 292 | 0.450 |
Why?
| | Biomarkers | 10 | 2020 | 3408 | 0.450 |
Why?
| | Heart Failure | 6 | 2015 | 1945 | 0.440 |
Why?
| | Risk Reduction Behavior | 1 | 2015 | 201 | 0.440 |
Why?
| | Coronary Disease | 2 | 2015 | 348 | 0.440 |
Why?
| | Precision Medicine | 1 | 2016 | 337 | 0.410 |
Why?
| | Arginine | 1 | 2013 | 238 | 0.400 |
Why?
| | Public Health | 1 | 2015 | 434 | 0.360 |
Why?
| | Risk Assessment | 9 | 2020 | 2968 | 0.360 |
Why?
| | Stroke Volume | 3 | 2011 | 504 | 0.340 |
Why?
| | Risk Factors | 13 | 2020 | 8632 | 0.330 |
Why?
| | Patient Safety | 1 | 2012 | 277 | 0.320 |
Why?
| | Neoplasms, Connective Tissue | 1 | 2008 | 3 | 0.310 |
Why?
| | Osteomalacia | 1 | 2008 | 4 | 0.310 |
Why?
| | Hypophosphatemia | 1 | 2008 | 15 | 0.310 |
Why?
| | Nose Neoplasms | 1 | 2008 | 15 | 0.310 |
Why?
| | Metformin | 1 | 2011 | 276 | 0.290 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2016 | 3252 | 0.280 |
Why?
| | Cardiovascular System | 1 | 2009 | 125 | 0.280 |
Why?
| | Troponin | 2 | 2016 | 44 | 0.260 |
Why?
| | Insulin Resistance | 1 | 2013 | 1072 | 0.250 |
Why?
| | Natriuretic Peptide, Brain | 3 | 2020 | 94 | 0.250 |
Why?
| | Humans | 32 | 2020 | 114696 | 0.240 |
Why?
| | Middle Aged | 20 | 2020 | 26737 | 0.240 |
Why?
| | Hospitalization | 2 | 2012 | 1752 | 0.240 |
Why?
| | Sex Distribution | 2 | 2015 | 337 | 0.230 |
Why?
| | Texas | 6 | 2014 | 188 | 0.230 |
Why?
| | Obesity | 2 | 2015 | 2508 | 0.220 |
Why?
| | Aged | 15 | 2020 | 19074 | 0.220 |
Why?
| | Male | 23 | 2020 | 55604 | 0.210 |
Why?
| | Female | 23 | 2020 | 59518 | 0.210 |
Why?
| | Oxygen Consumption | 4 | 2014 | 588 | 0.210 |
Why?
| | Rest | 2 | 2013 | 103 | 0.200 |
Why?
| | Sex Factors | 4 | 2017 | 1715 | 0.190 |
Why?
| | Cohort Studies | 4 | 2015 | 4895 | 0.190 |
Why?
| | Insulin | 1 | 2011 | 2080 | 0.190 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 1796 | 0.190 |
Why?
| | Peptide Fragments | 2 | 2020 | 666 | 0.180 |
Why?
| | Cross-Sectional Studies | 6 | 2017 | 4410 | 0.170 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2020 | 65 | 0.170 |
Why?
| | C-Reactive Protein | 2 | 2020 | 362 | 0.170 |
Why?
| | Education, Veterinary | 1 | 2019 | 2 | 0.160 |
Why?
| | Pets | 1 | 2019 | 20 | 0.160 |
Why?
| | Myocardium | 3 | 2014 | 913 | 0.150 |
Why?
| | Evidence-Based Medicine | 2 | 2012 | 668 | 0.150 |
Why?
| | Prospective Studies | 6 | 2015 | 6220 | 0.140 |
Why?
| | Electrocardiography | 1 | 2020 | 560 | 0.140 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 493 | 0.140 |
Why?
| | Aged, 80 and over | 3 | 2020 | 6347 | 0.140 |
Why?
| | Glycemic Index | 1 | 2016 | 21 | 0.140 |
Why?
| | Universities | 1 | 2019 | 340 | 0.140 |
Why?
| | Cardiac Output | 2 | 2013 | 143 | 0.130 |
Why?
| | Prognosis | 3 | 2013 | 3329 | 0.130 |
Why?
| | Transcutaneous Electric Nerve Stimulation | 2 | 2007 | 17 | 0.130 |
Why?
| | Early Diagnosis | 2 | 2014 | 217 | 0.130 |
Why?
| | Troponin I | 1 | 2016 | 68 | 0.130 |
Why?
| | Atherosclerosis | 3 | 2014 | 341 | 0.130 |
Why?
| | Time Factors | 4 | 2012 | 6116 | 0.120 |
Why?
| | Homoarginine | 1 | 2014 | 2 | 0.120 |
Why?
| | Follow-Up Studies | 3 | 2014 | 4411 | 0.120 |
Why?
| | Age Distribution | 1 | 2015 | 342 | 0.120 |
Why?
| | Hypercholesterolemia | 1 | 2015 | 90 | 0.120 |
Why?
| | Reference Values | 2 | 2014 | 743 | 0.110 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2014 | 34 | 0.110 |
Why?
| | United States | 3 | 2015 | 12185 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2014 | 1075 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2014 | 90 | 0.110 |
Why?
| | Biological Assay | 1 | 2014 | 112 | 0.110 |
Why?
| | Cholesterol | 1 | 2015 | 367 | 0.110 |
Why?
| | Triglycerides | 2 | 2014 | 467 | 0.110 |
Why?
| | Physical Fitness | 1 | 2014 | 179 | 0.110 |
Why?
| | Life Style | 1 | 2015 | 430 | 0.110 |
Why?
| | Curriculum | 1 | 2019 | 819 | 0.110 |
Why?
| | Blood Glucose | 2 | 2014 | 1828 | 0.100 |
Why?
| | Urban Population | 1 | 2015 | 397 | 0.100 |
Why?
| | Pilot Projects | 2 | 2014 | 1373 | 0.100 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2014 | 287 | 0.100 |
Why?
| | Renal Insufficiency | 1 | 2014 | 137 | 0.100 |
Why?
| | Adult | 9 | 2017 | 30552 | 0.100 |
Why?
| | Rural Population | 1 | 2015 | 446 | 0.100 |
Why?
| | Drug Approval | 1 | 2012 | 78 | 0.100 |
Why?
| | Survival Analysis | 2 | 2012 | 1211 | 0.090 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1079 | 0.090 |
Why?
| | Ventricular Function | 1 | 2011 | 57 | 0.090 |
Why?
| | Diabetic Nephropathies | 1 | 2014 | 234 | 0.090 |
Why?
| | Edema | 1 | 2011 | 119 | 0.090 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 534 | 0.080 |
Why?
| | Severity of Illness Index | 2 | 2014 | 2540 | 0.080 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 179 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1693 | 0.080 |
Why?
| | Colorado | 1 | 2019 | 4099 | 0.080 |
Why?
| | Young Adult | 2 | 2015 | 10471 | 0.080 |
Why?
| | Diabetes Complications | 1 | 2011 | 211 | 0.080 |
Why?
| | Coronary Artery Disease | 2 | 2015 | 607 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1430 | 0.080 |
Why?
| | Blood Pressure | 1 | 2015 | 1538 | 0.080 |
Why?
| | Registries | 2 | 2014 | 1768 | 0.080 |
Why?
| | Survival Rate | 1 | 2012 | 1644 | 0.080 |
Why?
| | Ilium | 1 | 2008 | 26 | 0.080 |
Why?
| | Hospital Mortality | 1 | 2012 | 776 | 0.080 |
Why?
| | Mass Screening | 1 | 2015 | 1005 | 0.080 |
Why?
| | Quinolines | 1 | 2009 | 129 | 0.080 |
Why?
| | United Kingdom | 1 | 2009 | 226 | 0.080 |
Why?
| | Delayed Diagnosis | 1 | 2008 | 70 | 0.070 |
Why?
| | Logistic Models | 1 | 2012 | 1841 | 0.070 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 932 | 0.070 |
Why?
| | Anticholesteremic Agents | 1 | 2009 | 128 | 0.070 |
Why?
| | Comorbidity | 1 | 2012 | 1448 | 0.070 |
Why?
| | Hypertension | 1 | 2015 | 1056 | 0.070 |
Why?
| | Age Factors | 1 | 2014 | 2894 | 0.070 |
Why?
| | Ambulances | 1 | 2007 | 50 | 0.070 |
Why?
| | Adolescent | 2 | 2015 | 17853 | 0.070 |
Why?
| | Emergency Medical Technicians | 1 | 2007 | 41 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1177 | 0.060 |
Why?
| | Hip Fractures | 1 | 2007 | 75 | 0.060 |
Why?
| | Atrial Natriuretic Factor | 1 | 2005 | 55 | 0.060 |
Why?
| | Transportation of Patients | 1 | 2005 | 52 | 0.060 |
Why?
| | Biopsy | 1 | 2008 | 1036 | 0.060 |
Why?
| | Models, Biological | 1 | 2011 | 1621 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1214 | 0.060 |
Why?
| | Low Back Pain | 1 | 2005 | 95 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2012 | 9088 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2009 | 2765 | 0.050 |
Why?
| | Exercise Test | 2 | 2014 | 544 | 0.040 |
Why?
| | Ventricular Function, Left | 2 | 2014 | 467 | 0.040 |
Why?
| | Double-Blind Method | 3 | 2011 | 1660 | 0.040 |
Why?
| | Hemodynamics | 2 | 2013 | 1012 | 0.040 |
Why?
| | Animals | 1 | 2019 | 31708 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 3 | 2014 | 3053 | 0.040 |
Why?
| | Prevalence | 2 | 2014 | 2251 | 0.030 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 20 | 0.030 |
Why?
| | Contraindications | 1 | 2014 | 85 | 0.030 |
Why?
| | Carbazoles | 1 | 2014 | 78 | 0.030 |
Why?
| | Urban Health | 1 | 2014 | 73 | 0.030 |
Why?
| | Propanolamines | 1 | 2014 | 90 | 0.030 |
Why?
| | Lymphotoxin beta Receptor | 1 | 2013 | 2 | 0.030 |
Why?
| | Glycation End Products, Advanced | 1 | 2013 | 57 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 178 | 0.030 |
Why?
| | ROC Curve | 1 | 2013 | 442 | 0.020 |
Why?
| | Aorta | 1 | 2014 | 386 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2013 | 249 | 0.020 |
Why?
| | Placebos | 1 | 2011 | 197 | 0.020 |
Why?
| | Plasma Volume | 1 | 2011 | 13 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2014 | 411 | 0.020 |
Why?
| | Ultrasonography | 1 | 2014 | 634 | 0.020 |
Why?
| | Hematocrit | 1 | 2011 | 87 | 0.020 |
Why?
| | Molecular Weight | 1 | 2011 | 331 | 0.020 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2014 | 358 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2011 | 258 | 0.020 |
Why?
| | Serum Albumin | 1 | 2011 | 137 | 0.020 |
Why?
| | Adiposity | 1 | 2014 | 458 | 0.020 |
Why?
| | Adiponectin | 1 | 2011 | 213 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2011 | 473 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 347 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 768 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 945 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2313 | 0.020 |
Why?
| | Weight Gain | 1 | 2011 | 453 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2387 | 0.020 |
Why?
| | Decision Making | 1 | 2013 | 782 | 0.020 |
Why?
| | Cytokines | 1 | 2013 | 1841 | 0.020 |
Why?
| | Body Mass Index | 1 | 2011 | 1959 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1226 | 0.010 |
Why?
| | Pain Measurement | 1 | 2005 | 444 | 0.010 |
Why?
| | Acute Disease | 1 | 2005 | 911 | 0.010 |
Why?
| | Heart Rate | 1 | 2005 | 709 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2007 | 590 | 0.010 |
Why?
| | Anxiety | 1 | 2005 | 840 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2013 | 12554 | 0.010 |
Why?
|
|
Gore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|